Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC S23 enterprise AI phone agent infrastructure with millions of simultaneous calls and sub-200ms latency; $65M total ($40M Emergence Series B Jan 2025 + $16M Scale/Levchin/Lawson Series A) competing with Retell AI for enterprise telephony.
Bland AI is a San Francisco-based enterprise AI phone call platform — backed by Y Combinator (S23) with $65 million in total funding including a $16 million Series A in August 2024 led by Scale Venture Partners with Y Combinator, Max Levchin (PayPal co-founder), and Jeff Lawson (Twilio founder), plus a $40 million Series B in January 2025 led by Emergence Capital — providing enterprises with a low-latency AI phone agent infrastructure that handles millions of simultaneous calls across multiple languages, serving customers including the Cleveland Cavaliers and Better.com. Founded in 2023 by Washington University graduates, Bland AI builds its own AI telephony infrastructure in-house (rather than using third-party APIs) to achieve the latency and reliability that enterprise phone operations require.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.